Literature DB >> 21155068

Doxercalciferol is as effective as calcitriol for the treatment of secondary hyperparathyroidism in CKD.

Katrina Ray.   

Abstract

Entities:  

Year:  2010        PMID： 21155068     DOI： 10.1038/nrneph.2010.149

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN： 1759-5061            Impact factor:   28.314


× No keyword cloud information.
  1 in total

1.  Calcitriol and doxercalciferol are equivalent in controlling bone turnover, suppressing parathyroid hormone, and increasing fibroblast growth factor-23 in secondary hyperparathyroidism.

Authors:  Katherine Wesseling-Perry; Renata C Pereira; Shobha Sahney; Barbara Gales; He-Jing Wang; Robert Elashoff; Harald Jüppner; Isidro B Salusky
Journal:  Kidney Int       Date:  2010-09-22       Impact factor: 10.612
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.